SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-036816
Filing Date
2020-08-05
Accepted
2020-08-05 16:12:22
Documents
3
Period of Report
2020-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K harp-8k_20200805.htm 8-K 31194
2 EX-99.1 harp-ex991_6.htm EX-99.1 187474
3 GRAPHIC gptrx52kfkbs000001.jpg GRAPHIC 3174
  Complete submission text file 0001564590-20-036816.txt   224385
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 201077406
SIC: 2836 Biological Products, (No Diagnostic Substances)